Follow

Submissions from 2024

PDF

Safety and Tolerability of Atogepant for the Preventive Treatment of Migraine: A Post Hoc Analysis of Pooled Data from Four Clinical Trials, Paul Rizzoli, Michael Marmura, Jennifer Robblee, Jennifer McVige, Sara Sacco, Stephanie Nahas, Jessica Ailani, Rosa De Abreu Ferreira, Julia Ma, Jonathan Smith, Brett Dabruzzo, and Messoud Ashina

PDF

Real-World Effectiveness of Add-Onfremanezumab in Patients Receiving OnabotulinumtoxinA for the Prevention of Chronic Migraine in a US Tertiary Headache Center: A Retrospective Chart Review Study, Hsiangkuo Yuan, Fred Cohen, Maurice T. Driessen, Lynda J. Krasenbaum, Mario Ortega, Mary Hopkins, and Michael J. Marmura

Submissions from 2023

PDF

A Novel Virtual-Based Comprehensive Clinical Approach to Headache Care, Thomas Berk, Stephen Silberstein, and Peter McAllister

PDF

Persistence to Anti-CGRP Monoclonal Antibodies and onabotulinumtoxinA Among Patients With Migraine: A Retrospective Cohort Study, Larry Charleston, Brian Talon, Christine Sullivan, Carlton Anderson, Steven Kymes, Stephane A. Regnier, Seema Soni-Brahmbhatt, and Stephanie J. Nahas

PDF

Drug-Free Noninvasive Thermal Nerve Block: Validation of Sham Devices, Michael Fishman, Ahish Chitneni, Alaa Abd-Elsayed, Samuel Grodofsky, Ashley Scherer, Brendan Schetzner, Malvina Klusek, Stephen Popielarski, Stephen Meloni, Steven Falowski, Philip Kim, Konstantin Slavin, and Stephen Silberstein

PDF

Novel Therapeutic Targets for Migraine, Areeba Nisar, Zubair Ahmed, and Hsiangkuo Yuan

PDF

Treatment of Chronic Migraine with Botox (Onabotulinumtoxina): Development, Insights, and Impact, Catherine C. Turkel, Sheena Aurora, Hans-Christoph Diener, David W. Dodick, Richard B. Lipton, Stephen D. Silberstein, and Mitchell F. Brin

Submissions from 2022

PDF

The Importance of an Early Onset of Migraine Preventive Disease Control: A Roundtable Discussion, Christopher Gottschalk, Anirban Basu, Andrew Blumenfeld, Bradley Torphy, Michael J. Marmura, Jelena M. Pavlovic, Paula K. Dumas, Nim Lalvani, and Dawn C. Buse

Submissions from 2020

PDF

Treatment patterns of patients diagnosed with major headache disorders: A retrospective claims analysis, David Kudrow, Sagar Munjal, Leah Bensimon, Tasneem Lokhandwala, Binglin Yue, Anna D’Souza Coutinho, and Stephen D. Silberstein

Submissions from 2014

PDF

Safety of topiramate for treating migraines., Michael J. Marmura

PDF

Letter to Alliance for Headache Disorders Advocacy, William B. Young, MD

Submissions from 2012

Link

Increased variability of motor cortical excitability to transcranial magnetic stimulation in migraine: a new clue to an old enigma., Adriana B Conforto, Mariana S Moraes, Edson Amaro, William B Young, Lais A Lois, André L Gonçalves, and Mario F P Peres

PDF

Onabotulinumtoxin A in the Treatment of Migraine Headache, Carrie O. Dougherty, MD and Stephen Silberstein, MD

PDF

Metabolic syndrome and migraine., Amit Sachdev and Michael J Marmura

Submissions from 2010

PDF

A new frontier for headache., Stephen Silberstein

Submissions from 2009

PDF

Early and Late Treatment of Migraine with DHE NS (Migranal®), Meryl Latsko, MD, MPH and Stephen D. Silberstein, MD

PDF

Frovatriptan as Preemptive Treatment for Fasting-Induced Migraine, Meryl Latsko, MD, MPH and Stephen D. Silberstein, MD

PDF

Dynamic mechanical (brush) allodynia in cluster headache: a prevalence study in a tertiary headache clinic., Michael J Marmura, Muhammad Abbas, and Avi Ashkenazi

Submissions from 2007

PDF

Cephalalgiaphobia: a possible specific phobia of illness., Mario F P Peres, Juliane P P Mercante, Vera Z Guendler, Felipe Corchs, Marcio A Bernik, Eliova Zukerman, and Stephen Silberstein

Submissions from 2005

PDF

The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE)., Paolo Martelletti, Redda T Haimanot, Miguel J A Láinez, Alan M Rapoport, K Ravishankar, Fumihiko Sakai, Stephen Silberstein, Maurice Vincent, and Timothy J Steiner